Vera Therapeutics, Inc.

Vera Therapeutics, Inc.verified

VERA

Price:

$42.61

Market Cap:

$2.72B

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartere...[Read more]

Industry

Biotechnology

IPO Date

2021-05-14

Stock Exchange

NASDAQ

Ticker

VERA

The PE Ratio as of December 2025 (TTM) for Vera Therapeutics, Inc. (VERA) is -10.68

According to Vera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.68. This represents a change of 10.44% compared to the average of -9.67 of the last 4 quarters.

Vera Therapeutics, Inc. (VERA) Historical PE Ratio (quarterly & annually)

How has VERA PE Ratio performed in the past?

The mean historical PE Ratio of Vera Therapeutics, Inc. over the last ten years is -8.26. The current -10.68 PE Ratio has changed 12.83% with respect to the historical average. Over the past ten years (40 quarters), VERA's PE Ratio was at its highest in in the December 2020 quarter at -1.37. The PE Ratio was at its lowest in in the June 2021 quarter at -20.13.

Quarterly (TTM)
Annual

Average

-8.26

Median

-6.31

Minimum

-17.43

Maximum

-0.80

Vera Therapeutics, Inc. (VERA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vera Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.08%

Maximum Annual PE Ratio = -0.80

Minimum Annual Increase = -75.96%

Minimum Annual PE Ratio = -17.43

Quarterly (TTM)
Annual
YearPE RatioChange
2024-15.38124.74%
2023-6.8418.52%
2022-5.77-66.89%
2021-17.432.08%
2020-0.80-75.96%

Vera Therapeutics, Inc. (VERA) Average PE Ratio

How has VERA PE Ratio performed in the past?

The current PE Ratio of Vera Therapeutics, Inc. (VERA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-9.33

5-year avg

-9.25

10-year avg

-8.26

Vera Therapeutics, Inc. (VERA) PE Ratio vs. Peers

How is VERA’s PE Ratio compared to its peers?

Vera Therapeutics, Inc.’s PE Ratio is less than Celldex Therapeutics, Inc. (-9.85), less than AbCellera Biologics Inc. (-6.35), less than Janux Therapeutics, Inc. (-9.98), less than Viridian Therapeutics, Inc. (-7.70), less than Pharvaris N.V. (-7.72), less than Immunome, Inc. (-8.23), less than Biohaven Ltd. (-1.30), less than uniQure N.V. (-5.66), less than Harmony Biosciences Holdings, Inc. (12.04), greater than Nuvation Bio Inc. (-13.08),

Build a custom stock screener for Vera Therapeutics, Inc. (VERA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vera Therapeutics, Inc. (VERA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Vera Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Vera Therapeutics, Inc. (VERA)?

What is the highest PE Ratio for Vera Therapeutics, Inc. (VERA)?

What is the 3-year average PE Ratio for Vera Therapeutics, Inc. (VERA)?

What is the 5-year average PE Ratio for Vera Therapeutics, Inc. (VERA)?

How does the current PE Ratio for Vera Therapeutics, Inc. (VERA) compare to its historical average?